KevinMD June 10, 2025
Shelli Pavone

The importance of diversity in clinical trials is well-documented, yet unfortunately the lack of diversity still occurs at an alarming rate. As a result, we continue to have less effective treatments, poorer health outcomes, one-size-fits-all medicine that falls short of many patients, and many more negative impacts on health care.

The reason for lack of diversity in clinical trials is similarly known, with language barriers, limited access to health care facilities conducting the trials, mistrust, and concerns about cost and time commitment being among some of the central causes. While the U.S. Census shows that 30 to 40 percent of the population are minorities, industry research shows that 80 percent of clinical trial participants are white and only 45 percent...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Pharma, Pharma / Biotech, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article